The n-butanol fraction (BF) of the EtOH extract of the aerial parts of C. eriocephalus var. albiflora was subjected to repeated chromatographic purifications, to afford a new sulfated flavonoid glycoside (16) , a phenylpropenoid glucoside (6) and a caffeic acid derivative (17) [9] [10] [11] . In addition, 5 aglycones (1-5), 6 monoglycosides (7-12) and 3 diglycosides (13) (14) (15) (all flavonoid in nature) were isolated and identified. The structures of the known compounds were established by comparing their UV, 1 H and 13 C NMR spectroscopic data with those in the literature [9] [10] [11] [12] [13] [14] [15] and confirmed through co-chromatography with authentic samples.
Compound 16 was obtained as a yellow amorphous powder. The presence of sulfate was confirmed by ESI-MS, in the positive ion mode, that showed a molecular ion peak at m/z 554.73 [M+4H] + , in accordance with the molecular formula C 21 H 19 O 14 SNa. The 1 H NMR spectrum showed the characteristic four resonances of a kaempferol 3-Osubstituted aglycone. An A 2 X 2 -spin system of two ortho coupled 2H doublets at δ 8.00 (2',6') and δ 6.84 (3',5'), characteristic for a 1,4-disubstituted B-ring was observed. In addition, an AM-spin coupling system of two meta-coupled protons at δ 6.06 and 16 δ 6.23 was assigned for H-6 and H-8, respectively.
The anomeric proton displayed at δ 5.38 (J = 8 Hz) indicated direct attachment to the 3-hydroxy group with β-configuration. The 13 C NMR spectrum displayed the characteristic 13 carbon resonances of a kaempferol 3-O-substituted aglycone [13] , together with six carbon resonances typical for a galactopyranoside. The signals of the sugar moiety revealed a downfield shift of C-6´´ by 3.6 ppm and an upfield shift of C-5´´ by 3 ppm, which confirmed the presence of a sulfate group at C-6´´ of a galactose unit. [16, 17] . Based on the previous discussion, compound 16 was identified as kaempferol 3-O-β-Dgalactopyranoside 6´´-sulfate.
The biological study revealed that the LD 50 values of the ethanolic (TEE) and aqueous extracts (TAE) of C. eriocephalus var. albiflora aerial parts were 4.1 and 3.8 g/kg, respectively. This biological study was undertaken to assess the antiperoxidation properties of C. eriocephalus var. albiflora in alloxan-induced diabetic rats. Alloxan acts through its uptake by β-cells due to its similarity to glucose [18] . In the cells, alloxan produces reactive oxygen species with a simultaneous massive increase in cytosolic calcium concentration. This causes the rapid destruction of β-cells [18] . Table 1 shows that a significant antihyperglycaemic effect was evident from the fourth week onwards; a decrease in blood glucose level was maximum on completion of the eighth week. The maximum reduction in glucose levels was seen in animals receiving BF in a dose of 100 mg/kg (62.7%), followed by TEE (54%).
GSH was decreased significantly in the plasma of diabetic rats. GSH is the first line of defense against a prooxidant status [20] and it was evaluated after administration of different fractions of C. eriocephalus var. albiflora at the end of the antihyperglycaemic study. GSH systems may have the ability to manage oxidative stress by adaptation of the enzyme regulating GSH metabolism. In the present study, treatment with different fractions of C. eriocephalus significantly increased GSH levels, which may in turn activate the GSH dependant enzymes, such as glutathione peroxidase and glutathione-S-transferase. Hence, it seems that the antihyperglycaemic action of the plant is partially due to its antioxidant action on pancreatic β-cells.
Both TEE and TAE (Table 2 ) decreased the cholesterol level after 8 weeks by 32.4% and 26.1%, respectively. BF was the most effective fraction; it decreased the cholesterol level by 44%, an effect which is not significantly different from Simvastatin, (53 % decrease). The n-hexane fraction (HF) was the least effective. TEE markedly decreased the triglycerides level (Table 2 ) by 33%. BF was the most potent fraction; it decreased the triglycerides level by 35%, an effect which was not significantly different from that of Simvastatin, which decreased it by 43.1% after 8 weeks.
TEE and TAE (Table 3) increased the level of HDL-c by 72% and 65.8%, respectively. All tested fractions were very potent, and were not significantly different from Simvastatin. BF was the most active fraction, which increased the level of HDL-c by 74%. (Table 3 ) decreased the level of LDL-c by 58% and 50%, respectively after 8 weeks. BF was the most effective fraction (75% decrease), and was not significantly different from the reference drug (Simvastatin), which decreased LDL-c by 83% after 8 weeks.
TAE and TEE (Table 3 ) decreased the risk factor by 68% and 70%, respectively. BF was the most potent, significantly reduced the LDL-c/HDL-c ratio (risk factor) by 85%, which was not significantly different from Simvastatin (which reduced the risk factor by 91.5%). Finally, one could conclude that the n-butanol fraction is very promising as an antihyperglycaemic, and antihyperlipidaemic, consequently, an intensive investigation to isolate the compound(s) responsible for these activities was the hope of the authors.
Experimental
General: Melting points were determined on a Kofler hot stage microscope. UV spectra were measured using a Shimadzu UV 240 (P/N 204-58000) spectrophotometer. HRESI-MS of compounds 6 and 17 were obtained using a TQ-FT-ICR (Liquid Transfer Quest-Fourier Transform-Ion Cyclotron Resonance) spectrometer, while ESI-MS of compound 16 was measured on a Thermo Finnigan (ion trap) ESI-MS machine.
1 H NMR spectra were measured with JEOL GLM ( 1 H NMR, 300 MHz, 13 C, 75 MHz, Japan) and JEOL JNM ECA 500 machines ( 1 H NMR, 500 MHz, 13 C, 125 MHz, Denmark). The NMR spectra were recorded in DMSO-d 6 
Extraction and isolation:
The air-dried and powdered flowering aerial parts of C. eriocephalus var. albiflora (500 g) were extracted with 70% EtOH, till exhaustion, (4 x 2.5 L) at 70 o C under reflux. The ethanolic extract was evaporated under reduced pressure to give 50 g of dark green residue, which was suspended in distilled water (200 mL) and partitioned successively with n-hexane (4 x 300 mL), chloroform (4 x 300 mL), and n-butanol (5 x 300 mL), to yield dry residues of 7 g (n-hexane fraction, HF), 6 g (chloroform fraction, CF), and 7 g (BF), after evaporation. For pharmacological study, another 300 g of the dried aerial parts of the plant were extracted and fractionated in the same way.
In addition, 100 g of powdered plant material was percolated with 500 mL hot water, followed by evaporation under reduced pressure. The residue was dissolved in sterile water before administration to rats. BF (7 g) was chromatographed over silica gel 60 H (Sigma) VLC (Ø10 x 20 cm, 100 g) with CHCl 3 , CHCl 3 -EtOAc mixtures, EtOAc and EtOAc-MeOH mixtures, with gradual increase of polarity, up to pure methanol. Fractions (100 mL) were collected and monitored by TLC under UV-light (245 nm and 365 nm), and p-anisaldehyde was used for detection. Similar fractions were pooled to give 11 fractions.
Fraction 1 (300 mg), fraction 2 (150 mg), fraction 3 (100 mg), fraction 5 (200 mg), fraction 7 (250 mg), and fraction 8 (200 mg) were subjected separately to repeated CC on Sephadex LH-20 with 10% aqueous MeOH as an eluent to give compounds 1 (100 mg, 0.02%), 2 (50 mg, 0.01%), 3 (30 mg, 0.006%), 6 (60 mg, 0.012%), 9 (100 mg, 0.02%), and 10 (70 mg, 0.014%), respectively. Fractions 4 (350 mg, 0.07%) and 9 (800 mg, 0.16%) were chromatographed separately by PPC (preparative paper chromatography) using Whatman No. 3 paper with (S1) n-BuOH-HOAc-H 2 O (4:1:5, top layer) for fraction 4, to give compounds 4 (100 mg, 0.02%) and 5 (40 mg, 0.008%), and with (S2) 15% aqueous HOAc for fraction 9, to give compounds 11 (250 mg, 0.05%) and 12 (150 mg, 0.03%). Fraction 6 (500 mg, 0.1%) was chromatographed by PTLC (preparative thin layer chromatography) using silica gel 60 G (Sigma) (CHCl 3 : MeOH, 8:2). The eluted fractions were purified by CC on Sephadex LH-20 with 10% aqueous MeOH as an eluent to give compounds 7 (200 mg, 0.04%), and 8 (120 mg, 0.024%). Fraction10 (1 g, 0.2%) was rechromatographed by CC on silica gel 100C 18 -reversed phase (70-230 mesh, Fluka) for column chromatography using acetonitrile: water (2:8) as eluent to afford compounds 13 (200 mg, 0.04%), 14 (20 mg, 0.004%), and 15 (250 mg, 0.05%). Finally, fraction 11 (800 mg, 0.16) was rechromatographed, also by CC on silica gel 100C 18 -reversed phase (70-230 mesh, Fluka) for column chromatography, using acetonitrile: water (1:9) as eluent, to afford compounds 16 (50 mg, 0.01%), and 17 (300 mg, 0.06%). 
